Jacob Naarden Van

Affiliations

  • Evp & Pres., Lilly Oncology at Eli Lilly & Co (LLY), 2024-11-01
  • Chief Operating Officer at Loxo Oncology Inc. (LOXO), 2019-02-15
Insider Trading: Sales See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
LOXO $140.16 541 Officer 13,700 2018-12-11 Filing
LOXO $139.23 500 Officer 14,241 2018-12-11 Filing
LOXO $137.73 500 Officer 14,741 2018-12-11 Filing
LOXO $137.09 1,759 Officer 15,241 2018-12-11 Filing
LOXO $135.92 800 Officer 17,000 2018-12-11 Filing